Fig. 1. Sustained virologic response at week 12 after end-of-treatment (SVR12) rates for patients with chronic hepatitis C.

Renal dysfunction was defined as an estimated glomerular filtration rate (eGFR) less than 60 (mL/m/1.73 m²). HCC, Hepatocellular carcinoma; CH, Chronic hepatitis; LC, Liver cirrhosis; GT, Genotype; SOF, Sofosbuvir; VEL, Velpatasvir; RBV, Ribavirin; DCV, Daclatasvir; ASV, Asunaprevir; LDV, Ledipasvir; PrOD, Paritaprevir/ritonavir, ombitasvir + dasabuvir; EBR, Elbasvir; GZR, Grazoprevir; GLE, Glecaprevir; PIB, Pibrentasvir; CI, Confidence interval.